20 percent of European Life Science companies have already chosen Switzerland as their HQ location. Are you next? Switzerland’s strategic location in the center of Europe, combined with the consolidation of the entire value chain in a single place, attracts international biotechnology firms to establish their presence here. Get in touch to learn more about the cornerstones of Switzerland's health ecosystem, rooted in strong research, the availability of specialized PhD professionals and lab technicians, and progressive regulatory conditions.
.
#WhySwitzerland
#WhySwitzerland
Develop partnerships to scale your business
The Swiss life science ecosystem is made up of innovative start-ups and multinational giants such as Roche, Novartis, Bayer, Abbott, Merck, Biogen, CSL Behring, Baxter, Johnson & Johnson, Hamilton, and Medtronic. These companies benefit from Switzerland’s experienced cluster along the entire value chain to develop, produce and market new products and services - from drug discovery to commercialization, all in one place.
If you are looking to set up supply chain and other headquarter functions, Switzerland provides excellent infrastructure and solutions for managing revenues and risks.
Enjoy a safe and innovative legal framework
Considering European expansion? Life Science companies favor Switzerland as a headquarter location for many reasons. Its central location, various trade agreements and progressive regulations make it easy for companies to tap into the European market, made up of almost 500 million consumers. A business-friendly environment and competitive corporate and personal tax rates provide further advantages for setting up headquarter functions in Switzerland.
20% of European Life Science companies have already chosen Switzerland as their HQ location, representing over 90 companies with active clinical trials. Life Science companies that already settled in Switzerland include Bluebird Bio, Roivant Sciences, BeiGene, Alnylam, Incyte, Biogen, Moderna, Luye Pharma, Align Technology, and Amgen.
Collaborate pragmatically with leading research institutes
Switzerland’s pragmatic collaboration between science and industry can help your company expedite the journey of your product to market. In a 2021 analysis of product pipelines by Biotechgate, Switzerland has the strongest product pipeline in Europe, after the UK.
Switzerland boasts an impressive investment in R&D, with pharmaceutical companies alone investing 9 billion Swiss francs in 2020. Ranked among the top countries for R&D expenditure relative to GDP, Switzerland sees private enterprises contributing a substantial two-thirds of the investment.
14 Swiss companies are ranked among the top 500 companies worldwide in terms of corporate research spending, with Roche ranked in 8th position and Novartis in 14th position.
Learn how your company can benefit from Switzerland’s unique focus on applied science.
Attract and retain the best people
Benefit from Switzerland’s talent pool - because it’s vast! Switzerland is a hub for PhD professionals in Life Sciences and related disciplines, with its top-ranking universities attracting diverse doctoral talent. Switzerland provides a rich talent pool for pharmaceutical, biotechnology, medical technology and digital health.
Switzerland's excellent quality of life, favorable tax policies and flexible work arrangements make it an attractive destination for C-level executives. Its renowned apprenticeship system ensures well-trained lab technicians or QC analysts with practical skills for the highly regulated life sciences sector and biologics manufacturing processes.
Find out more about talent in the Swiss health industry.
#SwissTech4Good
#SwissTech4Good
Use resources responsibly to meet current needs without jeopardizing those of future generations: this is how start-ups, scale-ups and corporations approach sustainability in Switzerland. We would like to show Switzerland’s impact in sustainability with the following example in this Ecosystem: The Fribourg-based biopharmaceutical company has invested more than 600 million Swiss francs in a state-of-the-art facility and aims to be carbon neutral by 2030.
Success Stories
Success Stories Medical Technology
Success Stories Biopharma
Success Stories Biopharma
Ecosystem Switzerland
Ecosystem Switzerland
The Swiss Biotech Association
The Swiss Biotech Association represents the interests of the Swiss biotech industry. Every new member helps to increase their impact and credibility. To support their members in a competitive market, they work to secure favorable framework conditions and facilitate access to talents, novel technologies and financial resources. At the same time, they provide platforms to connect and promote the biotech stakeholders.
Swiss Medtech
Swiss Medtech is the association of Swiss medical technology. They represent more than 750 companies. With 11.5% of Switzerland's positive trade balance, more than 67,500 employees and the most patents per inhabitant across Europe, the Swiss medical technology industry is of great economic importance. They are committed to an environment in which medical technology can deliver top performance for the benefit of first-class medical care.
Swiss Healthcare Startups
Swiss Healthcare Startups is a non profit organisation that supports innovative startups that aim to add value to the Swiss healthcare ecosystem. We support the startups by providing meaningful exposure and facilitating access to relevant stakeholders. As a neutral platform, we promote dialogue, networking and exchange throughout our ecosystem.
Swissmedic
Swissmedic is the Swiss authority for the licensing and monitoring of therapeutic products. It performs the mandate conferred upon it by law and works with partner authorities at home and abroad.
The authority ensures that the therapeutic products it approves are of faultless quality, effective and safe. In doing so it makes a significant contribution to safeguarding human and animal health and to maintaining Switzerland's role as a location for business and research.
Switzerland Innovation Park Basel Area
The Switzerland Innovation Park Basel Area is one of five sites in Switzerland Innovation’s network of science parks. At its four sites Allschwil, Basel, and Novartis Campus in Basel, the Switzerland Innovation Park Basel Area offers a total usable space of 9,432 m2. It connects and supports people with ideas and passion, gives them access to an innovative and cutting-edge infrastructure as well as a broad set of services so that they can focus on inventing, researching and shaping their future. There are currently about 510 people working at 74 companies and 12 research groups in the Switzerland Innovation Park Basel Area, which is managed by Basel Area Business & Innovation.
We have ve compiled information for your convenience, offering guidance on international expansion and selecting the ideal business location. Explore our comprehensive guide on the five essential areas:
Access to Ecosystem • Open Your HQ • Find Talent • Benefit from R&D • Locate Investors
Location Factors
Elevate Your Company’s Growth Potential
News
News
Do you want to know more about related fields?
